A 46-year-old woman, two children, full-time job, no significant medical history. She has been on three different SSRIs over the last five years. The first one helped for about a year, then stopped. The second one made her feel flat. The third one, current, is doing something but not enough — she is functional, she is not suicidal, but she is not herself. Her sleep is poor. Her libido is gone. She has gained 22 pounds. Her psychiatrist wants to add a second agent.
Her labs, when I run them: estradiol 18 pg/mL, progesterone undetectable, free testosterone below the functional range, SHBG elevated, free T3 in the bottom 10% of range, vitamin D at 22, ferritin at 14. She is not depressed in the way her psychiatrist has been treating her. She is hormonally and nutritionally depleted in a way that is producing a clinical picture that looks identical to depression and that has not responded to antidepressants because antidepressants are not the right tool for what is actually wrong.
I see this in patients all the time. The mood symptoms of perimenopause, hypothyroidism, low testosterone, iron deficiency, vitamin D deficiency, and the side effects of some of the medications used to treat them all overlap with major depression in ways that make purely psychiatric workups miss the diagnosis. This is not a critique of psychiatry. It is a critique of treating mood as if it lives in isolation from the endocrine and nutritional systems that drive it.
The mechanism — why hormones move mood
Mood is a downstream output of central nervous system activity. The neurotransmitter systems most implicated in mood — serotonin, dopamine, GABA, noradrenaline — are exquisitely sensitive to the hormonal milieu they operate within. The connections are not vague:
Estradiol modulates serotonin synthesis and serotonin receptor density. A drop in estradiol meaningfully reduces serotonergic tone. This is the mechanism behind the classic perimenopausal mood crash, behind premenstrual dysphoric disorder, and behind postpartum depression. The pattern is dose-dependent and the response to physiologic estradiol restoration is often rapid in patients who actually have an estradiol-driven picture.
Progesterone is metabolized to allopregnanolone, a positive allosteric modulator at the GABA-A receptor. That is the same receptor benzodiazepines act on. When endogenous progesterone declines, GABAergic tone declines with it, and the result is anxiety, irritability, sleep disruption, and in some patients a low-grade depressive picture that responds poorly to SSRIs.
Testosterone in both men and women supports dopaminergic tone, motivation, and the experience of agency. Low testosterone produces a flat, anhedonic, low-drive picture. In men, low T depression is a real entity that is consistently under-recognized in primary care. The patient describes losing his edge, losing his motivation, losing the willingness to start things he used to start without thinking about it.
Thyroid hormone drives cellular metabolism throughout the central nervous system. Suboptimal free T3, even with normal TSH, produces fatigue, slowed cognition, and mood symptoms that are routinely misattributed to depression. The literature on T3 augmentation in treatment-resistant depression exists for a reason.
Cortisol dysregulation — both elevated and blunted — disrupts mood, sleep architecture, and the HPA axis itself. Chronic stress states produce a depressive-looking picture that requires addressing the stress physiology, not just prescribing an antidepressant.
Insulin resistance and metabolic dysfunction produce mood symptoms through multiple mechanisms, including neuroinflammation, blunted serotonin synthesis from inadequate tryptophan transport, and disrupted hippocampal function. The "depression" of metabolic syndrome is often a metabolic problem first.
These mechanisms run in parallel. A 46-year-old woman with declining estradiol, low progesterone, suboptimal thyroid, and developing insulin resistance is not running one mood-disrupting process. She is running four of them, and treating any one of them in isolation predictably underperforms.
Why the standard mental health workup misses this
The standard primary care workup for new-onset depression in a mid-life patient is, in practice: PHQ-9 score, basic CBC, basic metabolic panel, TSH, vitamin D in some practices, B12 in some practices. That panel does not look at sex hormones at all. It does not look at free T3 or thyroid antibodies. It does not look at fasting insulin. It does not look at ferritin in any meaningful way (a ferritin of 14 will be flagged "normal" in most labs even though clinical iron repletion targets are usually 70 to 100).
The result is a workup that catches the most obvious organic contributors and misses the more subtle but no less treatable ones. If everything on that limited panel comes back inside the reference range, the patient gets an SSRI prescription and a follow-up in six weeks. If the SSRI helps, that is the answer. If it does not, the next step is usually a different SSRI, or augmentation, or referral to psychiatry.
What is rarely the next step: ordering the panel that would have caught the underlying picture in the first place.
How I evaluate a patient presenting with mood symptoms
When I evaluate someone for depression-spectrum symptoms in mid-life, the workup is broader than the standard psychiatric workup because the differential is broader. The questions I am answering before any treatment plan:
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
- Is there a hormonal contributor? Sex hormones, thyroid, cortisol pattern.
- Is there a metabolic contributor? Insulin resistance, glucose dysregulation, lipid profile.
- Is there a nutritional contributor? Iron, B12, folate, vitamin D, magnesium.
- Is there an inflammatory contributor? hs-CRP, ferritin used as inflammation marker, autoimmune markers if indicated.
- Is there a sleep architecture problem? Sleep disordered breathing, fragmented sleep, circadian disruption.
- Is there a medication contributor? Beta-blockers, statins, SSRIs themselves, oral contraceptives, opioids, sedating antihistamines.
- Is there a primary mental health condition that needs psychiatric care alongside any medical workup?
The answer to #7 is sometimes yes, and when it is, I refer or co-manage with a psychiatric provider. These workups are not zero-sum. A patient can have major depressive disorder and also have undiagnosed Hashimoto's, and treating only one of them will leave her sick. The point is not to replace psychiatry. The point is to make sure the medical workup actually happens before psychiatry is asked to fix everything alone.
What I look for on the [comprehensive lab work](/start-here)
The panel I order on a mid-life patient with mood symptoms:
- Sex hormones: estradiol, progesterone, total and free testosterone, DHEA-S, SHBG. In men, add LH, FSH, and prolactin.
- Thyroid: TSH, free T3, free T4, reverse T3, TPO and thyroglobulin antibodies.
- Metabolic: fasting insulin, HbA1c, fasting glucose, full lipid panel, comprehensive metabolic panel.
- Nutritional: vitamin D, B12, folate, ferritin, magnesium (RBC magnesium when available).
- Inflammatory: hs-CRP, ESR if indicated, ANA if autoimmune signs are present.
- CBC with differential.
That is roughly twelve to fifteen markers beyond what most primary care depression workups include. Most of those markers are inexpensive. The yield is high enough that I order them by default in this presentation, not as a hedge.
What treatment looks like once the picture is clear
Treatment depends on what the workup reveals. The patterns I see most often:
Perimenopausal mood with low estradiol and low progesterone. Hormone optimization using transdermal estradiol and oral micronized progesterone. Most patients in this picture report meaningful mood improvement at four to six weeks and durable change at three months. This is not a substitute for an SSRI in a patient who actually needs one — but in a patient whose mood picture was driven by hormonal decline, the SSRI was never going to do what hormone replacement does.
Low testosterone in a male patient. Workup for primary versus secondary hypogonadism, then men's hormone therapy when appropriate. Mood and motivation are usually the first symptoms to respond — often within four weeks of reaching therapeutic levels.
Suboptimal thyroid with normal TSH. Address the conversion issue (selenium, zinc, ferritin), address autoimmune drivers if Hashimoto's is in the picture, and consider T3 augmentation in patients with persistent symptoms despite optimized T4. Mood often improves dramatically when free T3 actually moves into the upper third of the range.
Insulin resistance and metabolic syndrome. Metabolic program addressing weight, insulin sensitivity, and inflammation. Mood improvement here is slower — usually visible at eight to twelve weeks — but it is durable in a way that medication-only approaches are not.
Iron deficiency. Aggressive repletion, oral or IV depending on severity and tolerance. Targets are functional repletion (ferritin 70 to 100), not minimum reference range. Mood and energy responses are often striking when the deficit was real.
Vitamin D deficiency. Repletion to a 25-OH level of 50 to 80 ng/mL. Maintenance dosing afterward. The mood literature on vitamin D is mixed in unselected populations and clearer in deficient ones.
Combination pictures, which is most patients. Treatment is sequenced based on what is most addressable and most likely to produce early improvement. The patient knows what we are doing and why, and we reassess on a defined cadence.
A note on staying on existing medications
If you are on an antidepressant that is helping at all, I do not pull you off it as part of starting a hormone or nutritional workup. We add what is missing, we reassess at three months, and any conversation about tapering happens later in coordination with your prescribing provider. The point is not to take away what is working. The point is to add what should have been there.
Concrete next step
If you are in middle Georgia — Columbus, Warner Robins, Fort Benning, anywhere in between — and you have been treating depression for more than a year with incomplete results, or your mood symptoms emerged in your 40s alongside other unexplained changes, the gap to close is the medical workup. Bring me whatever recent labs you have, bring a current medication and supplement list, and bring a brief written timeline of when symptoms started and what has changed. If your last panel did not include the markers above, I will order them at the first visit. Book a Columbus consultation or Warner Robins consultation and mention mood symptoms at intake so the longer slot gets allocated. We sit with the data at visit two and build the plan from what is actually driving the picture.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.